Novo Nordisk shares jump 8% on U.S. Wegovy pill approval
Shares of Novo Nordisk surged nearly 8% after the U.S. FDA approved its Wegovy weight-loss pill. The landmark decision marks a major expansion for the obesity drug market.
Shares of Novo Nordisk surged nearly 8% after the U.S. FDA approved its Wegovy weight-loss pill. The landmark decision marks a major expansion for the obesity drug market.
U.S. regulators have greenlit a pill version of a leading weight-loss medication, potentially broadening treatment options. Learn about the approval and its implications.
U.S. regulators have approved the Wegovy pill for weight loss, a major development in pharmaceutical treatment. Learn about the details and potential impact of this new drug.
Former VP Mike Pence demands Health Secretary Robert F. Kennedy Jr. resign, citing failure on pro-life promises. The controversy centers on a safety review of the abortion pill mifepristone.
The U.S. FDA's current COVID-19 vaccine chief is facing a scathing denunciation over new claims. Health experts and officials react to the controversy unfolding in December 2025.
An FDA official's internal memo reveals at least 10 child deaths linked to COVID-19 vaccines, prompting proposed vaccine policy reforms and stricter authorization requirements.
ByHeart recalls all organic baby formula products nationwide after 15 infants hospitalized with botulism. Parents urged to immediately dispose of contaminated formula.
U.S. FDA removes long-standing warning from hormone-based menopause drugs, recognizing significant benefits for women's health. Learn what this means for Canadian women.
The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.
Discover how the FDA's landmark approval of Casgevy, the first CRISPR-based treatment, is transforming genetic medicine and offering hope for sickle cell patients.